column

Anchoring the core of technology on an unshakable foundation. The true value of Veneno, preserved and continuously refined by Director and Chief Technology Officer (CTO) Tadashi Kimura.

In the turbulent world of biotech startups, Veneno Technologies has carved out a distinctive position of its own. At the heart of that achievement lies Director and CTO Tadashi Kimura’s uncompromising devotion to technology, a commitment he has sustained over many years. Since the company’s founding, Kimura has remained at the forefront of its research, refining complex peptide technologies into practical, real-world applications. We trace his journey—how he has consistently supported the company’s progress from a technical standpoint—and explore his vision for the next generation of researchers.

A Challenge from Scratch: The Determination That Turned the “Impossible” of DRP Synthesis into “Everyday Reality”

Tadashi Kimura’s journey is, in many ways, the history of Veneno Technologies’ technological evolution itself. In the early days of the company, when the efficient synthesis of “disulfide-rich peptides (DRPs)” was still a global challenge, Kimura spent more time than anyone else in the lab poring over data. While theoretically possible, numerous obstacles stood in the way when it came to actual implementation. He overcame each one through meticulous experimental design and persistent verification. The existence of the PERISS method—our current high-throughput screening technology—and the integrated end-to-end DRP creation platform Veneno Suite is entirely due to Kimura’s ability to transform the “lessons learned from failure” accumulated over many years into the “reliable reproducibility” necessary for success.

Preserving the Integrity of Technology
And Sustaining the Power to Keep a Startup Moving Forward

Kimura’s role as CTO is not simply to create something new. It is also to protect the core of the technology, ensuring that the direction of research never wavers, and to uphold a deeply sincere commitment to generating data that society can trust.

In a biotech startup, continuing research and sustaining the company itself are never easy. While pursuing technical breakthroughs, Kimura has also placed great importance on the practical challenge of connecting those breakthroughs to business opportunities and new strategic partnerships. His uncompromising attitude toward science, demonstrated day after day in the lab, has become a silent textbook for younger researchers and has helped elevate the professionalism of the organization as a whole.

Passing the Baton to the Next Generation
Technology Is Refined by People and Carried into the Future

After many years of safeguarding the front line of technology, Kimura is now focusing his energy most intensely on the transfer of knowledge to the next generation. He has generously shared the vast expertise he has built around DRPs with talented younger researchers such as Tanaka, Okamoto, and Nguyen.

Kimura often says, “The moment a technology is completed, it begins to belong to the past. That is why we must always bring in new perspectives and continue to update it.” The technological foundation he has spent years protecting at Veneno is now blending with the fresh ideas of a younger generation, branching out into new possibilities in drug discovery, agriculture, and beyond.

The thread spun by Tadashi Kimura, a researcher of quiet passion, is now expanding into something much larger: a network of innovation with the potential to help change the world.

Related Post